Quillaja saponin adjuvant and vaccine formulation containing...

Details Quillaja saponin adjuvant and vaccine formulation containing... Quillaja saponin adjuvant and vaccine formulation containing...

C - Chemistry, Metallurgy

07

J

C07J 63/00 (2006.01) A61K 39/29 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2190344

A novel saponin component having a molecular weight of about 956 daltons, a process for isolating the saponin component from the bark of Quillaja saponaria Molina, a vaccine formulation comprising the saponin component as an immune adjuvant, a method for increasing the immune response to an antigen by employing an adjuvant composition comprising saponin component and a second adjuvant.

Cette invention concerne un nouveau composant de saponine d'un poids moléculaire d'environ 956 Daltons, un procédé d'isolation du composant de saponine de l'écorce de Quillaja saponaria Molina, une formulation de vaccin comprenant le composant de saponine en tant qu'adjuvant immunitaire, un procédé permettant d'accroître la réponse immunitaire à un antigène grâce à une composition d'adjuvant contenant le composant de saponine, ainsi qu'un second adjuvant.

Affiliated with

Also associated with

Rating

Quillaja saponin adjuvant and vaccine formulation containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quillaja saponin adjuvant and vaccine formulation containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quillaja saponin adjuvant and vaccine formulation containing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1901531